Alexandra M. Nanzer

Guy's And St Thomas' NHS Trust
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Advances in the treatment of eosinophilic granulomatosis with polyangiitis.

Advances in the treatment of eosinophilic granulomatosis with polyangiitis.

Journal: Nature reviews. Rheumatology

Published: June 24, 2026

Identifying the residual unmet need in severe asthma.

Identifying the residual unmet need in severe asthma.

Journal: The Lancet. Respiratory medicine

Published: May 29, 2026

Application of T2 Biomarkers to Support Steroid Stewardship in Severe Asthma - a retrospective cohort study.

Application of T2 Biomarkers to Support Steroid Stewardship in Severe Asthma - a retrospective cohort study.

Journal: The journal of allergy and clinical immunology. In practice

Published: January 06, 2026

Application of T2 biomarkers to support steroid stewardship in severe asthma-a retrospective cohort study.

Application of T2 biomarkers to support steroid stewardship in severe asthma-a retrospective cohort study.

Journal: The journal of allergy and clinical immunology. In practice

Published: January 06, 2026

Development of the UK Severe Asthma Registry as a performance-monitoring quality improvement platform.

Development of the UK Severe Asthma Registry as a performance-monitoring quality improvement platform.

Journal: BMJ open quality

Published: January 04, 2026

Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA): Do We Need Immunosuppressives?

Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA): Do We Need Immunosuppressives?

Journal: The journal of allergy and clinical immunology. In practice

Published: September 08, 2025

Adherence to Inhaled Corticosteroids and Clinical Outcomes Following a Year of Tezepelumab Therapy for Severe Asthma.

Adherence to Inhaled Corticosteroids and Clinical Outcomes Following a Year of Tezepelumab Therapy for Severe Asthma.

Journal: The journal of allergy and clinical immunology. In practice

Published: June 05, 2025

Fractional exhaled nitric oxide as a novel biomarker of relapse in eosinophilic granulomatosis with polyangiitis.

Fractional exhaled nitric oxide as a novel biomarker of relapse in eosinophilic granulomatosis with polyangiitis.

Journal: American journal of respiratory and critical care medicine

Published: May 26, 2025

Tezepelumab in Patients With Eosinophilic Granulomatosis With Polyangiitis After Suboptimal Response to Anti-IL-5/5R Therapy.

Tezepelumab in Patients With Eosinophilic Granulomatosis With Polyangiitis After Suboptimal Response to Anti-IL-5/5R Therapy.

Journal: Chest

Published: May 06, 2025

Adverse outcomes in young adults with severe asthma: results from the UK Severe Asthma Registry.

Adverse outcomes in young adults with severe asthma: results from the UK Severe Asthma Registry.

Journal: ERJ open research

Published: April 17, 2025

Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma.

Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma.

Journal: Allergy

Published: February 20, 2025

Newly diagnosed eosinophilic granulomatosis with polyangiitis in patients on biologics for severe asthma: A multicenter case series.

Newly diagnosed eosinophilic granulomatosis with polyangiitis in patients on biologics for severe asthma: A multicenter case series.

Journal: The journal of allergy and clinical immunology. In practice

Published: November 20, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026